Ac3 - Discordant Designations of Breakthrough Drug Innovation: France Versus the United States

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Analysis of Orphan Drug Designations and Approvals in the United States and the European Union

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Drug Reimportation Practices in the United States

Therapeutics and Clinical Risk Management
Chemical HealthPharmacologySafetyMedicineToxicologySafety ResearchPharmaceutics
2007English

The United States Versus the Rest of the World

English

A Comparison of Outcomes in Clinical Trials Conducted Within the United States Versus Outside the United States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

The FDA's Definitions, Designations, and Drug Approvals: Too Daring?

The Lancet Haematology
Hematology
2018English

Alcohol- And Drug-Involved Driving in the United States

Evaluation Review
ArtsSocial SciencesHumanities
2011English

Drug Importation Into the United States: Impact on Canada

CMAJ
Medicine
2017English

Perceptions of International Strategic Moves: Saudi Arabia Versus the United States

South African Journal of Business Management
ManagementInternational ManagementBusinessStrategy
2015English

Perchlorate in Dairy Milk. Comparison of Japan Versus the United States

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy